Hospices Civils de Lyon, Department of Hematology, Lyon-Sud Hospital, Pierre Bénite 69495, France Therapy-related acute myeloid leukaemia and acute myeloid leukaemia with myelodysplasia-related ...
Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials This phase III, open-label study ...
Five-year follow-up data from the phase 3 CLTR0310-301 clinical trial shows continued OS benefit with the novel agent CPX-351 in acute myeloid leukemia subgroups. Treatment with CPX-351 (Vyxeos) in ...
Donor Lymphocyte Infusions Modulate Relapse Risk in Mixed Chimeras and Induce Durable Salvage in Relapsed Patients After T-Cell–Depleted Allogeneic Transplantation for Hodgkin's Lymphoma Fig 1.
Abu Dhabi, UAE – CPX, a leading provider of cutting-edge cyber and physical security solutions and services, today unveiled its strategic expansion plan to accelerate growth, broaden its global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback